Chemotherapy for Lung Cancer

Overview

Chemotherapy is a common form of treatment for lung cancer. It is a systemic therapy, meaning it is administered either orally or intravenously throughout the body to target both cancer cells and healthy cells. Chemotherapy works by stopping the growth of cancer cells, which can lead to their destruction, the prevention of cancer from spreading, and a decrease in the size of tumors. It is often used in combination with other treatments, such as radiation and surgery, to provide more effective outcomes. The success of chemotherapy for lung cancer depends on the location and stage of the cancer, as well as the overall health of the patient. Chemotherapy is an important tool in treating lung cancer and can significantly improve outcomes for many patients.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 3 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.

• Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer
  Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
• J591 functionalized paclitaxel loaded PLGA nanoparticles successfully inhibited PSMA overexpressing LNCaP cells
  Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
• Excerpts from Flaws in Medicine Must Be Corrected: An Open Report to National Governments Amid the Pandemic
  2020 ·
• Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
  2019 · Journal of Experimental and Clinical Toxicology

A sample of recent works citing this journal's research on Chemotherapy for Lung Cancer, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics